Skip to content

Drug interactions

Elranatamab + Ropinirole

Severity: Moderate

Elranatamab and Ropinirole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cytokine release syndrome from elranatamab can transiently suppress CYP enzymes, which may increase exposure to CYP1A2 substrates such as ropinirole. This could amplify ropinirole adverse effects like hypotension and somnolence around step-up dosing and during CRS.

What this interaction means in plain words

Elranatamab and Ropinirole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elranatamab belongs to Oncology; Ropinirole belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP1A2 reduces ropinirole clearance during CRS.

What to do

Monitor for ropinirole adverse effects, especially orthostatic hypotension and sedation, during step-up dosing and any CRS episode. Consider a temporary dose reduction if symptomatic.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elranatamab and Ropinirole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elranatamab with Ropinirole?

MediHelp rates the interaction as moderate. Elranatamab and Ropinirole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cytokine release syndrome from elranatamab can transiently suppress CYP enzymes, which may increase exposure to CYP1A2 substrates such as ropinirole. This could amplify ropinirole adverse effects like hypotension and somnolence around step-up dosing and during CRS.

How serious is the interaction between Elranatamab and Ropinirole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ropinirole adverse effects, especially orthostatic hypotension and sedation, during step-up dosing and any CRS episode. Consider a temporary dose reduction if symptomatic.

What other medicines interact with Ropinirole?

MediHelp also lists interactions of Ropinirole with, for example, Amisulpride, Chlorpromazine, Droperidol. The full list is on the Ropinirole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in